A Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Endometrial Carcinoma

被引：0
|
作者：
Makker, Vicky [1 ]
Rasco, Drew [2 ]
Dutcus, Corina [3 ]
Stepan, Daniel [3 ]
Li, Di [3 ]
Schmidt, Emmett [4 ]
Shumaker, Robert [3 ]
Young, Louise [5 ]
Taylor, Matthew [6 ]
机构：
[1] Mem Sloan Ketting Canc Ctr, New York, NY USA
[2] START, San Antonio, TX USA
[3] Eisai Inc, Woodcliff Lake, NJ USA
[4] Merck Co Inc, Kenilworth, NJ USA
[5] Eisai Australia Pty Ltd, Melbourne, Vic, Australia
[6] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
235
引用
收藏
页码：152 / 153
页数：2
相关论文
共 50 条
  • [1] A phase Ib/II trial of lenvatinib (LEN) plus pembrolizumab (Pembro) in patients (Pts) with endometrial carcinoma.
    Makker, Vicky
    Rasco, Drew W.
    Dutcus, Corina E.
    Stepan, Daniel E.
    Li, Di
    Schmidt, Emmett V.
    Shumaker, Robert Charles
    Taylor, Matthew H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] A Phase IB/II Trial of Lenvatinib plus Pembrolizumab in Patients With Renal Cell Carcinoma
    Lee, Chung-Han
    Makker, Vicky
    Rasco, Drew
    Taylor, Matthew
    Dutcus, Corina
    Shumaker, Robert
    Schmidt, Emmett
    Stepan, Daniel E.
    Li, Di
    Young, Louise
    Motzer, Robert
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 153 - 153
  • [3] Phase Ib/II trial of lenvatinib plus pembrolizumab in urothelial cancer.
    Vogelzang, Nicholas J.
    Encarnacion, Carlos A.
    Cohn, Allen Lee
    DiSimone, Christopher
    Rasco, Drew W.
    Richards, Donald A.
    Taylor, Matthew H.
    Dutcus, Corina E.
    Stepan, Daniel E.
    Shumaker, Robert Charles
    Guo, Matthew
    Schmidt, Emmett V.
    Mier, James Walter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [4] Phase Ib/II trial of lenvatinib plus pembrolizumab in advanced melanoma.
    Taylor, Matthew H.
    Vogelzang, Nicholas J.
    Cohn, Allen Lee
    Stepan, Daniel E.
    Shumaker, Robert Charles
    Dutcus, Corina E.
    Guo, Matthew
    Schmidt, Emmett V.
    Rasco, Drew W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [5] Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors
    Taylor, Matthew H.
    Lee, Chung-Han
    Makker, Vicky
    Rasco, Drew
    Dutcus, Corina E.
    Wu, Jane
    Stepan, Daniel E.
    Shumaker, Robert C.
    Motzer, Robert J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (11) : 1154 - +
  • [6] Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma
    Finn, Richard S.
    Ikeda, Masafumi
    Zhu, Andrew X.
    Sung, Max W.
    Baron, Ari D.
    Kudo, Masatoshi
    Okusaka, Takuji
    Kobayashi, Masahiro
    Kumada, Hiromitsu
    Kaneko, Shuichi
    Pracht, Marc
    Mamontov, Konstantin
    Meyer, Tim
    Kubota, Tomoki
    Dutcus, Corina E.
    Saito, Kenichi
    Siegel, Abby B.
    Dubrovsky, Leonid
    Mody, Kalgi
    Llovet, Josep M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26) : 2960 - +
  • [7] Lenvatinib plus Pembrolizumab in advanced Endometrial Carcinoma
    Lorenz, Judith
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (05) : 464 - 464
  • [8] Pembrolizumab Plus Lenvatinib Approved in Advanced Endometrial Carcinoma
    Schuyler, Devon
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 610 - 610
  • [9] A Phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results
    Ikeda, Masafumi
    Sung, Max W.
    Kudo, Masatoshi
    Kobayashi, Masahiro
    Baron, Ari D.
    Finn, Richard S.
    Kaneko, Shuichi
    Zhu, Andrew X.
    Kubota, Tomoki
    Kralijevic, Silvija
    Ikezawa, Hiroki
    Siegel, Abby B.
    Kumada, Hiromitsu
    Okusaka, Takuji
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [10] A phase Ib trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC): Updated results
    Llovet, J.
    Shepard, K. V.
    Finn, R. S.
    Ikeda, M.
    Sung, M.
    Baron, A. D.
    Kudo, M.
    Okusaka, T.
    Kobayashi, M.
    Kumada, H.
    Kaneko, S.
    Pracht, M.
    Mamontov, K.
    Meyer, T.
    Mody, K.
    Kubota, T.
    Saito, K.
    Siegel, A. B.
    Dubrovsky, L.
    Zhu, A. X.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
12345